Premium
P4‐153: Subjective Cognitive Decline and Progression to Dementia Due to AD and Non‐AD in Memory Clinic and Community‐Based Cohorts
Author(s) -
Slot Rosalinde E.R.,
Sikkes Sietske A.M.,
Verfaillie Sander C.J.,
Wolfsgruber Steffen,
Brodaty Henry,
Buckley Rachel F.,
Hampel Harald,
Kochan Nicole A.,
Luck Tobias,
Maruff Paul,
Molinuevo Jose Luis,
Kornhuber Johannes,
Reisberg Barry,
Riedel-Heller Steffi G.,
Roehr Susanne,
Sachdev Perminder S.,
Scarmeas Nikolaos,
Scheltens Philip,
Visser Pieter Jelle,
Vos Stephanie J.B.,
Wagner Michael,
Jessen Frank,
van der Flier Wiesje M.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.2245
Subject(s) - dementia , prodrome , memory clinic , incidence (geometry) , medicine , cognition , cognitive decline , gerontology , confidence interval , alzheimer's disease , pediatrics , rate ratio , disease , psychiatry , physics , psychosis , optics
PROGRESSION TO DEMENTIA DUE TO AD AND NON-AD IN MEMORY CLINIC AND COMMUNITYBASED COHORTS Rosalinde E. R. Slot, Sietske A. M. Sikkes, Sander C. J. Verfaillie, Steffen Wolfsgruber, Henry Brodaty, Rachel F. Buckley, Harald Hampel, Nicole A. Kochan, Tobias Luck, Paul Maruff, Jose Luis Molinuevo, Johannes Kornhuber, Barry Reisberg, Steffi G. Riedel-Heller, Susanne Roehr, Perminder S. Sachdev, Nikolaos Scarmeas, Philip Scheltens, Pieter Jelle Visser, Stephanie J. B. Vos, MichaelWagner, Frank Jessen, Wiesje M. van der Flier, Neuroscience Campus Amsterdam, Amsterdam, Netherlands; Alzheimer Center, VU University Medical Center, Amsterdam, Netherlands; 3 DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany; 4 Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany; University of New South Wales, Sydney, Australia; Centre for Healthy Brain Ageing UNSW Australia, Sydney, Australia; 7 The Florey Institutes of Neurosciences and Mental Health, Melbourne, Australia; 8 University of Melbourne, Melbourne, Australia; AXA Research Fund & UPMC Chair, Paris, France; Universit e Pierre et Marie Curie, Paris, France; Centre for Healthy Brain Ageing, UNSW, Sydney, Australia; 12 Neuropsychiatric Institute, Prince of Wales Hospital, Randwick, Australia; Institute of Social Medicine, Occupational Health and Public Health (ISAP), Faculty of Medicine, University of Leipzig, Leipzig, Germany; 14 Cogstate Ltd., Melbourne, Australia; 15 ICN Hospital Clinic Universitari and Pasqual Maragall Foundation,, Barcelona, Spain; Friedrich-Alexander University Erlangen-N€urnberg, Erlangen, Germany; New York University Alzheimer’s Disease Center, NYU Langone Medical Center, New York, NY, USA; 18 National and Kapodistrian University of Athens, Athens, Greece; Department of Neurology, Columbia University Medical Center, New York, NY, USA; Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; 21 VU University Medical Center, Amsterdam, Netherlands; Maastricht University, Maastricht, Netherlands; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; 24 Psychiatry Department, University of Cologne, Cologne, Germany; 25 DZNE, German Center for Neurodegenerative Diseases, Cologne, Germany; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands. Contact e-mail: re.slot@vumc.nl